UPSC NDA & NA 2 Exam Registration 2023: Interested and eligible candidates can apply for the same by visiting the official website of the Commission at upsc.gov.in. aaa
As Incyte Corporation’s recently-minted Opzelura gets off to the races in eczema, the drug has run up against a setback in another dermatology indication.
Biogen and Sage Therapeutics’ race to bring depression drug zuranolone to market is entering the home stretch. After talking to the FDA, the partners have outlined plans to start a rolling submission early in 2022 and complete the filing in the second half of the year.